Vital Farms (VITL) Stock Forecast and Price Target 2024 (2024)

FAQs

Vital Farms (VITL) Stock Forecast and Price Target 2024? ›

According to our current VITL stock forecast, the value of Vital Farms shares will rise by 1.31% and reach $ 41.39 per share by May 29, 2024. Per our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).

The average price target for Vital Farms is $37.83. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $45.00 ,the lowest forecast is $24.00. The average price target represents -2.89% Decrease from the current price of $38.954.

Stock Prediction 2025. The Bitfarms Ltd. stock prediction for 2025 is currently $ 4.96, assuming that Bitfarms Ltd. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 143.10% increase in the BITF stock price.

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for WELL Health Technologies is C$7.13, with a high forecast of C$10.00 and a low forecast of C$4.75.

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Bitfarms is $4.00, with a high forecast of $5.00 and a low forecast of $3.00. The consensus rating for Bitfarms stock is Buy based on the current 5 buy ratings for BITF.

The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $34.40. Get Vital Farms alerts: Several research firms recently weighed in on VITL.

Institutional Ownership and Shareholders

These institutions hold a total of 32,299,077 shares. Largest shareholders include BlackRock Inc., William Blair Investment Management, Llc, Vanguard Group Inc, Amazon Com Inc, Bank Of America Corp /de/, TWCGX - Growth Fund Investor Class, Lord, Abbett & Co.

Will the stock market recover in 2024? ›

While there could be a growth slowdown in the first half of 2024, experts believe growth should resume in the second half of the year. Americans faced many financial challenges this year, from persistent inflation to increasingly expensive debt.

Target Stock Price Forecast 2024-2025

The forecasted Target price at the end of 2024 is $207 - and the year to year change +45%. The rise from today to year-end: +29%. In the middle of 2024, we expect to see $168.

Despite the near-term weakness, WELL Health offers excellent buying opportunities for long-term investors, given the expanding addressable markets and attractive valuation.

For the full year, analysts project that Meta's revenue will rise 17.8% to $158.9 billion in 2024, after climbing 15.7% last year, according to FactSet. Revenue slipped 1.1% in 2022. Meta's earnings are expected to grow this year but at a slower rate compared to Meta's 2023 recovery year.

A recent report predicts that Bitcoin will reach a new all-time high in 2024. Bitcoin (BTC) is expected to reach a new record of $88,000 (€82,000) throughout the year, before it settles around $77,000 at the end of 2024, according to a new report. The cryptocurrency's current price sits at around $43,000.

The current TTM dividend payout for Vital Farms (VITL) as of May 14, 2024 is $0.00. The current dividend yield for Vital Farms as of May 14, 2024 is 0.00%.

According to Vital Farms's latest financial reports the company's current revenue (TTM ) is $0.47 B. In 2022 the company made a revenue of $0.36 B an increase over the years 2021 revenue that were of $0.26 B. The revenue is the total amount of income that a company generates by the sale of goods or services.

Based on analyst ratings, Verve Therapeutics's 12-month average price target is $28.00. What is VERV's upside potential, based on the analysts' average price target? Verve Therapeutics has 349.44% upside potential, based on the analysts' average price target.